Submit Your Science to TCT® 2025.
Showcase Your Research, Cases, and Innovations to a Global Audience
Access an Opportunity To Join the Prestigious TCT® Faculty
Transform the Future of Interventional Cardiology
Submit your groundbreaking science for an opportunity to present on a global stage and join the prestigious TCT® 2025 faculty. Imagine sharing your research with the brightest minds in interventional cardiology and connecting with a global network of innovators!
Submission DeadlinesAdd these dates to your calendar.
Submission Categories and Guidelines
Challenging Cases
Physicians and fellows worldwide: Submit your most challenging coronary, endovascular, and structural heart disease cases. The best cases will be chosen by the course directors for presentation. Accepted submissions will be reviewed by the editors of JACC Case Reports, and the top cases may be invited for publication.
Submission Guidelines
- Enter the relevant information on the CRF® submission platform, as prompted. A PowerPoint slide presentation is optional.
- Character limit: 2,450 total, including case summary, history, diagnostic tests, procedure, conclusion, and comments. Each image reduces your character limit by 600. Each table reduces your character limit by 300.
- Images: 10 MB maximum.
- Video formats: 30 MB mpeg, wmv, avi, mov, mpg, mp4.
Notification
Accepted presenters will be notified in September.
Abstracts
Submit your abstracts of original research for the opportunity to present to thousands of your colleagues worldwide. Research can be in the form of clinical studies, basic science investigations, or preclinical studies and must be relevant to interventional cardiology, endovascular medicine, or structural heart disease. Your abstracts must convey original research but can include portions of previous abstracts and/or manuscripts presented or published elsewhere.
Accepted abstracts will be published in the Journal of the American College of Cardiology (JACC).
Note About Submission Categories
- We strongly encourage you to submit your research to both the Abstracts and Late-Breaking Clinical Trials and Science/FIH and EFS categories. Doing so gives your work the opportunity to be considered for both presentation formats, potentially increasing its visibility and impact. Please check the relevant box on the submission site to indicate if you have submitted the same work to both categories.
- Submit single-patient case reports to Challenging Cases, regardless of the novelty of the case.
Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award
Younger than 40? Committed to academic and research excellence and have the accomplishments to demonstrate it? Apply for the Young Investigator Award!
The Linnemeier Award is designed to inspire young physicians to pursue a lifelong commitment to clinical and academic excellence. This prestigious award honors achievements in interventional cardiovascular medicine and aims to stimulate continued dedication to exceptional patient care and ongoing academic research by emerging investigators.
The finalists will become faculty at TCT® 2025. The winner will be announced at the conference and will receive the award along with a $10,000 scholarship on the podium at TCT® 2025.
Innovation Sessions and TCT® Shark Tank Innovation Competition
Innovation Sessions
Submit your novel technologies relevant to the monitoring, diagnosis, and treatment of coronary, endovascular, or structural heart disease. Selected emerging technologies will be presented at TCT® 2025. Submissions will be evaluated by a group of external reviewers and graded analogously to the science and case submissions.
TCT® Shark Tank Innovation Competition
Enter the Shark Tank! The annual TCT® conference is the preeminent platform for concept-stage presentations of novel technologies in interventional cardiovascular medicine. Submit concept-stage novel technologies in interventional cardiovascular medicine for a chance to present to a panel of expert judges and compete for an award of $200,000 provided by the Jon DeHaan Foundation.
Late-Breaking Clinical Trials and Science / First-in-Human and Early Feasibility Studies
Late-Breaking Clinical Trials and Science Are Typically
- First-time presentations of first-in-human experiences with novel devices or drugs.
- Primary or important secondary endpoint results of prospective randomized clinical trials.
- Large-scale, impactful single-/multicenter observational studies/registries.
If Your Submission Is Accepted
- You will present it at TCT® 2025.
- You must commit to providing your presentation slides a week prior to the conference.
- It will be featured in the press conferences scheduled for the same day.
Note About Submission Categories